The investment seeks to track the performance of the S&P U... Show more
The Vanguard Dividend Appreciation ETF tracks the S&P U.S. Dividend Growers Index, a market-cap-weighted benchmark of U.S. companies that have increased their annual dividends for at least 10 consecutive years. Importantly, the index excludes the top 25% of highest-yielding names, which helps it avoid distressed "yield traps" and instead emphasize financially durable, growing businesses.
The portfolio holds roughly 340 stocks, with a total net asset base exceeding $110 billion (AUM, or assets under management) and an expense ratio of just 0.04%. Geographically, the fund is essentially all U.S. equity exposure. Sector-wise, technology leads at roughly 26% of assets, followed by financials (about 21%), healthcare (about 18%), and industrials (about 11–12%), with smaller positions in consumer staples, consumer discretionary, energy, materials, and utilities.
Top holdings include Microsoft, Apple, Broadcom, JPMorgan Chase, Eli Lilly, Exxon Mobil, Johnson & Johnson, Visa, Walmart, and Mastercard. Because the strategy favors dividend growth over current yield, the fund behaves less like a traditional income portfolio and more like a quality large-cap growth vehicle — a structural characteristic that ties its future performance potential closely to the earnings and innovation cycles of its largest holdings.
Several developments could shape the fund's trajectory:
The macro outlook is pivotal for this ETF because its sector mix is unusually concentrated in rate-sensitive and growth-oriented segments. A technology allocation near 26% ties performance to the semiconductor cycle, cloud-computing budgets, and AI capital expenditures. A financials weighting above 20% links the fund to the credit cycle, loan growth, and the shape of the yield curve.
In a higher-for-longer interest-rate environment, large banks can benefit from wider net interest margins, while technology valuations may face pressure from elevated discount rates. Conversely, a rate-cutting cycle could compress bank earnings but support multiple expansion in growth stocks and provide a tailwind for the broader equity market. Healthcare exposure — led by Eli Lilly and Johnson & Johnson — adds a defensive, innovation-driven layer that is less correlated to the economic cycle. Energy and materials, though modest in size, remain tied to global demand and commodity prices.
Because the index excludes the highest-yielding stocks, the fund tends to carry a lower dividend yield (roughly 1.5%) but greater capacity for payout and earnings growth. This blend of growth-leaning technology, cyclical financials, and defensive healthcare means the macro outlook — rather than any single sector — is the dominant determinant of the fund's forward path.
For traders looking to complement fundamental research with data-driven signals, Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the coming week or month. The platform is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. It includes searchable prediction categories, historical context, and alert-oriented functionality to support more informed decision-making. Explore the Trend Prediction Engine to see how its signals align with your own market view.
Over the long term, the fund's structural positioning aligns with several durable investment themes. The rise of AI and enterprise cloud adoption supports sustained earnings growth among its technology holdings, while an aging demographic tailwind underpins healthcare demand. A gradual shift toward shareholder-friendly capital-return policies across corporate America reinforces the index's core dividend-growth mandate.
Interest-rate cycles will remain a recurring influence, but the fund's quality tilt — companies with a decade or more of consecutive payout increases — has historically favored balance-sheet strength and earnings consistency. As global investors increasingly favor low-cost, rules-based equity exposure, this ETF's blend of dividend growth and large-cap quality positions it squarely within long-running market trends favoring passive, factor-oriented investing.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ISUL | 18.57 | 0.38 | +2.12% |
| GraniteShares 2x Long ISRG Daily ETF (ISUL) | |||
| SEIS | 31.71 | 0.04 | +0.13% |
| SEI Select Small Cap ETF (SEIS) | |||
| TSEC | 25.10 | N/A | +0.02% |
| Touchstone Securitized Income ETF (TSEC) | |||
| QIS | 11.50 | N/A | N/A |
| Simplify Multi-QIS Alternative ETF (QIS) | |||
| BKLC | 47.98 | -0.31 | -0.64% |
| BNY Mellon US Large Cap Core Equity ETF (BKLC) | |||
A.I.dvisor indicates that over the last year, VIG has been closely correlated with XTR. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if VIG jumps, then XTR could also see price increases.
Category LargeBlend
VIG moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend. In 25 of 29 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on VIG as a result. In 65 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for VIG just turned positive on October 05, 2026. Looking at past instances where VIG's MACD turned positive, the stock continued to rise in 39 of 50 cases over the following month. The odds of a continued upward trend are 78%.
The 10-day moving average for VIG crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Following a +1.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIG advanced for three days, in 267 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 287 of 363 cases where VIG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 19 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
VIG broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.